Join
Live feed
·
INSIDERFilingvia Quantisnow
Avalo Therapeutics Inc. logo

Chief Strategy Officer Riley Jennifer was granted 34,200 shares, increasing direct ownership by 1,288% to 36,855 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AVTX· Avalo Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVTX (Avalo Therapeutics Inc.) and more on Quantisnow.